no statement of use filed
on 28 Nov 2022
Last Applicant/ Owned by
2042 Corte del Nogal
Carlsbad
CA
92011
Serial Number
90566145 filed on 08th Mar 2021
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
"THERAPEUTICS"
The mark consists of A stylized circle having two regions of shading gradients and inside the circle there are a series of dots with some of the dots having a lines originating from the dots or connecting the dots, underneath the stylized circle is the word "qualigen" in a stylized font in lowercase letters, underneath "qualigen" is the word "therapeutics" between the "q" and the "g" of "qualigen"Read More
Medical devices for use in treating or diagnosing viral infections; Medical devices for use in treating or diagnosing cancer
No 90566145
No Service/Collective Mark
No QLG01-011-TM
No
No
No
No
No
No
No
No
26.01.20 -
Circles within a circle
26.01.21 -
Circles that are totally or partially shaded
26.17.01 -
Straight line(s), band(s) or bar(s)
26.17.06 -
Diagonal line(s), band(s) or bar(s)
The mark consists of A stylized circle having two regions of shading gradients and inside the circle there are a series of dots with some of the dots having a lines originating from the dots or connecting the dots, underneath the stylized circle is the word "qualigen" in a stylized font in lowercase letters, underneath "qualigen" is the word "therapeutics" between the "q" and the "g" of "qualigen" in a stylized font in capital letters and the "i" in "qualigen" has a lighter shaded dot.
| Status Date | Action Taken |
|---|---|
| 28th Nov 2022 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 28th Nov 2022 | ABANDONMENT - NO USE STATEMENT FILED |
| 21st Jul 2022 | CORRECTED NOA E-MAILED |
| 20th Jul 2022 | DIVISIONAL PROCESSING COMPLETE |
| 18th Jul 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 22nd Jun 2022 | DIVISIONAL REQUEST RECEIVED |
| 22nd Jun 2022 | TEAS REQUEST TO DIVIDE RECEIVED |
| 27th Apr 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 25th Apr 2022 | SOU EXTENSION 1 GRANTED |
| 25th Apr 2022 | SOU EXTENSION 1 FILED |
